Endogenous neurotrophins and Trk signaling in diffuse large B cell lymphoma cell lines are involved in sensitivity to rituximab-induced apoptosis

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Bellanger, Cynthia ^a   Dubanet, Lydie ^a   Lise, Marie Claude ^a   Fauchais, Anne Laure ^a   Bordessoule, Dominique ^a,b   Jauberteau, Marie Odile ^a   Troutaud, Danielle ^a  

^a UNIVERSITY OF LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; K 252A; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A; RITUXIMAB; SORTILIN; ANTINEOPLASTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN 3 RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOMA CELL LINE; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; B CELL LYMPHOMA; DRUG RESISTANCE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTOR, TRKB; RECEPTOR, TRKC; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 80455150287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027213     Document Type: Article

References (38)

1. De Paepe P, De Wolf-Peeters C, (2007) Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities. Leukemia 21: 37-43.
2. Coiffier B, Pfreundschuh M, Stahel R, Vose J, Zinzani PL, (2002) Aggressive lymphoma: improving treatment outcome with rituximab. Anticancer Drugs 13: 43-50.
3. Coiffier B, (2007) Rituximab therapy in malignant lymphoma. Oncogene 26: 3603-3613.
4. Davis RE, Brown KD, Siebenlist U, Staudt LM, (2001) Constitutive nuclear factor κB activity is required for survival of activated B cell like diffuse large B cell lymphoma cells. J Exp Med 94: 1861-1874.
5. Uddin S, Hussain AR, Siraj AK, Manogaran PS, Al-Jomah NA, et al. (2006) Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108: 4178-4186.
6. Bonavida B, (2007) Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions. Oncogene 26: 3629-3636.
7. Bibel M, Barde YA, (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14: 2919-2937.
8. Holgado-Madruga M, Moscatello DK, Emlet DR, Dieterich R, Wong AJ, (1997) Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc Natl Acad Sci U S A 94: 12419-12424.
9. Arevalo JC, Wu SH, (2006) Neurotrophin signaling: many exciting surprises! Cell Mol Life Sci 63: 1523-1537.
10. Dechant G, (2001) Molecular interactions between neurotrophin receptors. Cell Tissue Res 305: 229-238.
11. Wang X, Bauer JH, Li Y, Shao Z, Zetoune FS, et al. (2001) Characterization of a p75(NTR) apoptotic signaling pathway using a novel cellular model. J Biol Chem 276: 33812-33820.
12. Lee R, Kermani P, Teng KK, Hempstead BL, (2001) Regulation of cell survival by secreted proneurotrophins. Science 294: 1945-1948.
13. Teng HK, Teng KK, Lee R, Wright S, Tevar S, et al. (2005) ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 25: 5455-5463.
14. Levi-Montalcini RS, Skaper D, Dal Toso R, Petrelli L, Leon A, (1996) Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19: 514-520.
15. Coppola V, Barrick CA, Southon EA, Celeste A, Wang K, et al. (2004) Ablation of TrkA function in the immune system causes B cell abnormalities. Development 131: 5185-5195.
16. Schuhmann B, Dietrich A, Sel S, Hahn C, Klingenspor M, et al. (2005) A role for brain-derived neurotrophic factor in B cell development. J Neuroimmunol 163: 15-23.
17. Otten U, Ehrhard P, Peck R, (1989) Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci U S A 86: 10059-10063.
18. Melamed I, Kelleher CA, Franklin RA, Brodie C, Hempstead B, et al. (1996) Nerve growth factor signal transduction in human B lymphocytes is mediated by gp140trk. Eur J Immunol 26: 1985-1992.
19. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, et al. (1996) Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85: 345-356.
20. Torcia M, De Chiara G, Nencioni L, Ammendola S, Labardi D, et al. (2001) Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. J Biol Chem 276: 39027-39036.
21. Abram M, Wegmann M, Fokuhl V, Sonar S, Luger EO, et al. (2009) Nerve growth factor and neurotrophin-3 mediate survival of pulmonary plasma cells during the allergic airway inflammation. J Immunol 182: 4705-4712.
22. Pearse RN, Swendeman SL, Li Y, Rafii D, Hempstead BL, (2005) A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood 105: 4429-4436.
23. Sniderhan LF, Garcia-Bates TM, Burgart M, Bernstein SH, Phipps RP, et al. (2009) Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma. Exp Hematol 37: 1295-1309.
24. Fauchais AL, Lalloue F, Lise MC, Boumediene A, Preud'homme JL, et al. (2008) Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival. J Immunol 181: 3027-3038.
25. Carnahan J, Stein R, Qu Z, Hess K, Cesano A, et al. (2007) Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab. Mol Immunol 44: 1331-1341.
26. Verdier M, Malissein E, Munteanu E, Jayat-Vignoles C, Ratinaud MH, et al. (2006) Aged mice exhibit distinct peripheral B-cell phenotypes differing in apoptotic susceptibility: an ex vivo analysis. Cytometry A 69: 999-1009.
27. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 40: 503-511.
28. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947.
29. Lyu MA, Rai D, Ahn KS, Sung B, Cheung LH, et al. (2010) The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo. Neoplasia 12: 366-375.
30. Skeldal S, Matusica D, Nykjaer A, Coulson EJ, (2011) Proteolytic processing of the p75 neurotrophin receptor: A prerequisite for signalling?: Neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR). Bioessays 33: 614-625.
31. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, et al. (2004) Sortilin is essential for proNGF-induced neuronal cell death. Nature 427: 843-848.
32. Rose CR, Blum R, Pichler B, Lepier A, Kafitz KW, et al. (2003) Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature 426: 74-78.
33. Tervonen TA, Ajamian F, De Wit J, Verhaagen J, Castren E, et al. (2006) Overexpression of a truncated TrkB isoform increases the proliferation of neural progenitors. Eur J Neurosci 24: 1277-1285.
34. Akil H, Perraud A, Mélin C, Jauberteau MO, Mathonnet M, (2011) Fine-Tuning Roles of Endogenous Brain-Derived Neurotrophic Factor, TrkB and Sortilin in Colorectal Cancer Cell Survival. PLoS ONE 6 (9): e25097 doi:10.1371/journal.pone.0025097.
35. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, et al. (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142: 436-440.
36. Rezvani AR, Maloney DG, (2011) Rituximab resistance. Best Pract Res Clin Haematol 24: 203-216.
37. Suzuki E, Umezawa K, Bonavida B, (2007) Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis. Oncogene 26: 6184-6193.
38. Stein R, Qu Z, Chen S, Rosario A, Shi V, et al. (2004) Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma. Clin Cancer Res 10: 2868-2878.